GLP-1 Pill Foundayo Shows Promise in Treating Obstructive Sleep Apnea Through Weight Loss
Rapid Read

GLP-1 Pill Foundayo Shows Promise in Treating Obstructive Sleep Apnea Through Weight Loss

What's Happening? The GLP-1 pill orforglipron, marketed as Foundayo, has demonstrated benefit in treating obstructive sleep apnea (OSA), primarily through its effect on weight loss. Clinical trials, including the ATTAIN-OSA studies involving 712 adults with obesity and moderate to severe OSA, showed
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.